INTRODUCTION
Neurofibromatosis type 1 (NFl), also known as von Recklinghausen disease, is an autosomal dominant disorder that occurs at a frequency of 1 in 4000 (Crowe et aZ., 1956; Stumpf et al., 1988) . NFl is a clinical diagnosis defined by criteria developed through a consensus conference at the National Institutes of Health (Stumpf et al., 1988) . The most common physical signs of this condition are multiple subcutaneous nodules (neurofibromas) and pigmented patches of skin (cafeau-lait spots). Patients with NFl are at significantly increased risk for development of malignancies (e.g., see Riccardi and Eichner, 1986) . The NFl locus has been mapped, by means of genetic linkage studies, to the vicinity of the centromere of human chromosome 17 (Barker et aZ., 1987; Seizinger et al., 1987; Goldgar et al., 1989) ; recently its location has been narrowed to band 17q11.2 (Schmidt et al., 1987; Ledbetter et al., 1989) .
A strategy for cloning and characterizing the NFl gene took form when two independent translocations, both with breakpoints located within band 17q11.2, were found in NFl patients. Because the translocations are the likely cause of neurofibromatosis in these patients, presumably through alteration of the structure or expression of the normal gene at the NFl locus, the translocation breakpoints provide two operational definitions of genomic clones near the locus. Provided that the two breakpoints do not occur at exactly the same place, some components of the gene would likely map between them.
To test this hypothesis, a large number of cosmid DNA probes were isolated from two somatic cell hybrid lines that each contain only a small segment of human chromosome 17. These cosmid clones have been mapped to the NFl region by genetic linkage and by physical methods (Fountain et aZ., 1989a; O'Connell et al., 1989a) . We recently reported that two of these probes identified a large DNA fragment that differed in size between normal and translocation chromosomes (Fountain et aZ., 1989b; O'Connell et al., 1989b) .
In addition to the DNA probes developed from somatic cell hybrids, we examined cloned DNAs having oncogenic potential and known to map to this region.
In particular, the oncogenes ERBAl and ERBB2 were examined because they had been localized to the relevant region of chromosome 17. Mapping studies, however, excluded both ERB genes from the vicinity of the NFl locus (unpublished data).
In contrast, mapping studies were unable to exclude a putative protooncogene recently identified in murine myeloid tumors (Buchberg et al., submitted for publication) as a candidate for the NFl gene. Because the mouse gene mapped to a region of murine chromosome 11 that shows extensive homology to human chromosome 17 (Buchberg et al., 1988 (Buchberg et al., ,1989 , its human counterpart was potentially located near the NFl locus. Genetic linkage studies in a large panel of reference families revealed that the human homolog, EVI2, does reside on human chromosome 17, very near other genetic marker loci that are closely linked to the NFl locus. More precise mapping with somatic cell hybrids containing the segregated translocation chromosomes placed EVI2 between the two NFl translocation breakpoints and made it a strong candidate for the NFl gene.
MATERIALS AND METHODS

Cell Lines
Epstein-Barr virus-transformed lymphoblastoid cell lines from normal and NFl individuals were suspension-cultured in RPM1 1640 medium (Cellgro/Mediatech), with 1% Nutridoma (Boehringer-Mannheim), 5% bovine calf serum (Hyclone), and 50 units/ml gentamicin sulfate. NFl individuals were defined by the criteria of Stumpf et al. (1988) and were collected under the auspices of the National Neurofibromatosis Foundation or diagnosed by one of us (J.C.C.). The somatic cell hybrids used in this study (identified in Fig. 1 ) were cultured in D-MEM (Cellgro/Mediatech) containing 10% fetal bovine serum (Hyclone), supplemented with hypoxanthine, aminopterin, and thymidine (HAT, Boehringer-Mannhiem) to selectively retain chromosome 17; however, hybrid 123B was cultured without HAT.
Southern Analysis
Human DNA samples derived from a panel of 59 reference families (White et al., 1985; Dausset, 1986) were digested using 96-well trays and a BiomeklOOO laboratory workstation (Beckman). For somatic cell hybrids, 5 pg of control and 10 pg of hybrid DNA were digested. Restriction enzyme digests were carried out according to instructions supplied by the manufacturer (Molecular Biology Resources), except that enzymes were used in twofold excess (5X for MspI). Restriction enzyme-digested samples were fractionated on 0.8% agarose gels in TEAC buffer as previously described (Barker et aZ., 1984; Cavenee et aZ., 1984) . Transfers were to Gelman Biotrace RP filters in 0.4 N NaOH (Reed and Mann, 1985) . Radiolabeling of DNA probes was performed according to Feinberg and Vogelstein (1984) . DNA plugs for PFGE were prepared in lowmelting-point agarose (Schwartz and Cantor, 1984) and run on a variety of boxes including FIGE (Carle and Olsen, 1984) , TAFE (Gardiner et al., 1986) , and CHEF (Chu et al., 1986) . Electrophoresis took place in l.O-1.5% agarose gels in 0.5~ TBE buffer; DNA gels were depurinated by two 5-min washes in 0.25 M HCl, immediately before transfer.
Hybridizations took place in 50% formamide, 5X SSC, 50 mM NaP04 (pH 6.5), 2X Denhardt's solution, and 200 pg/ml sheared, denatured human DNA at 42'C. Human DNA was included to suppress hybridization to repetitive sequences by radiolabeled cosmids or their subclones. Washes were in 0.1X SSC, 0.1% SDS at 55-65'C.
Genetic Linkage Analysis
Genotypic data were entered into a computer database, and the output listings were checked against the autoradiograms to avoid clerical errors. In addition, all data for recombination of closely linked markers were re-inspected to determine whether misidentification of parents or grandparents was inflating recombination estimates.
Linkage analysis was performed with the LINEAGE program, which provides an iterative method for determining a probable gene order and likely alternatives (Lathrop et al., 1985) .
Genomic Libraries
Genomic libraries were prepared from Sau3A partial digests of genomic DNA, fractionated on lo-40% sucrose gradients (Seed et al., 1982) , and cloned into bacteriophage or cosmid vectors. Phage lifts were carried out with 0.45-pm Biotrans filters (Pall Biodyne) by the method of Benton and Davis (1977) . Cosmid colonies were lifted onto 1.2~pm Biotrans filters (Pall Biodyne) by the method of Grunstien and Hogness (1975) .
RESULTS
Hybridization of a human genomic library with an evolutionarily well-conserved, unique-sequence murine genomic probe for the Ed-2 locus, pXS1.9, identified a human genomic DNA clone, phage HU39. A subclone of phage HU39, pHU39.3, revealed a two-allele EcoRI restriction fragment length polymorphism (RFLP) with a major allele of 9.5 kb and a minor allele of 7.3 kb (Buchberg et al., unpublished data) . Following the conventions for human nomenclature, we now refer to the human locus as E V12. This marker had an observed heterozygosity of 0.45 in 100 unrelated individuals typed. Linkage analysis gave a maximum lod score of 16.1 at zero recombination between the locus identified by pHU39.3 and the locus defined by cll-2Cl1, a cos- .
Cell line DCRl contains the derivative chromosome 1 [der(l) ] from an NFl patient with a different balanced translocation, t(1;17)(p34.3;q11.2) (Menon et al, 1989) .
The chromosome 17 content of these hybrid cell lines is illustrated in Fig. la .
Because both NFl translocation hybrid cell lines retain the long arm of chromosome 17, a gene mapping between the breakpoints would be expected to show no hybridization to DNA from the hybrid containing the more distal of the two translocation breakpoints, but would hybridize to DNA from the hybrid cell containing the translocation breakpoint nearer the centromere. Figure lb shows the hybridization results for one such probe, E-9, an EV12 cDNA clone (Cawthon et al., 1990) . The absence of the human band in lane 4 shows that E-9 sequences are missing from the t(17;22) breakpoint chromosome (NF13). The presence of the human band in lane 5 indicates that E-9 sequences are present in the t(1;17) breakpoint chromosome (DCRl); this single-copy human locus therefore maps to a region between the NFl translocation breakpoints.
This result also locates the t(17;22) breakpoint distal to the t(1;17) breakpoint (see Fig. la) .
The nature of the rearrangements, however, might be complex; the E VI2 sequences could be missing from NF13 due to an interstitial deletion, for example.
Therefore, further support for the localization of E VI2 sequences between the translocation breakpoints was sought from analysis of DNA in lymphoblastoid cell lines (LCL), derived from normal individuals and from the two NFl patients with translocations, by pulsedfield gel electrophoresis (PFGE). We previously described two loci, defined by probes pl7LlA and clllF10, that map respectively to the proximal and distal ends of a 600-kb NruI fragment. This NruI fragment is rearranged in both NFl translocation hybrids (Fountain et al., 1989b; O'Connell et al., 1989b) . Figure 2a shows the PFGE-derived map of the region, deduced from the data shown in Table 1 . The approximate positions of the NFl translocations are shown. Several HTF islands (Bird, 1986) are indicated by the clusters of restriction sites for enzymes with CpG dimers in their recognition sites. The order centromere-17LlA-t(l;17)-EV12-t(17;22)-11-lFlO-telomere is indicated by the mapping of E VI2 between the translocation breakpoints, with 17LlA proximal and 11-1FlO distal to both breakpoints. PFGE analysis of fragments from the translocation chromosomes has provided further support for this order. Since all of these probes are mapped to the same NruI fragment in normal lymphoblasts (Fig. 2b) , the order shown above predicts that specific derivative NruI fragments, associated with each of the translocation chromosomes, should also be identified by probes for the EV12 locus. Specifically, EV12 and cll-1FlO
should map to the same derivative NruI fragment of the t(1;17) translocation chromosome. Figure 2c shows that both EV12 and cll-1FlO are found on the same 450-kb derivative NruI fragment of the t(1;17) translocation chromosome, whereas p17LlA is found on a derivative fragment with an apparent mobility identical to that of the normal NruI fragment. Similarly, pl7LlA
and EV12 are found on the same 480-kb derivative NruI fragment of the t(17;22) translocation chromosome, whereas cll-1FlO is found on a derivative of 390 kb (Fig. 2d) . (P) denotes products of partial digestion.
To better localize the NFl translocation breakpoints and provide probes for identifying transcribed regions, cosmid-walking experiments were undertaken. Radiolabeled pHU39.3 identified two contiguous human cosmid clones, designated cEVI20 and cEVI36, from a human genomic library cloned in a derivative of pWE15. A second walk with a radiolabeled 2.1-kb EcoRI subclone (pT320) from the end of cEVI20 identified two additional overlapping cosmids, designated cT311 and cT315. Restriction mapping experiments with these clones resulted in the cosmid contig map shown in Fig.  3a , spanning approximately 80 kb of genomic DNA.
A series of probes spanning the cosmid contig were tested against DNA blots of the BumHI-, BgZII-, and EcoRI-digested DNA from the NFl translocation somatic cell hybrid panel in Fig. la . As previously shown in Fig. lb , probe E-9, which is homologous to the 9-kb EcoRI fragment shown in Fig. 3a and reflects sequences found in both cEVI20 and cEVI36, maps between the translocation breakpoints because it is absent in hybrid NF13 and present in hybrid DCRl. Probe GE1.O is a 1-kb BglII-EcoRI restriction fragment from cEVI36. As shown in Fig. 3b , it detects an 11.5-kb genomic EcoRI fragment that maps to chromosome 17q, but is absent in both translocation hybrids. Therefore, this fragment of cEVI36 must map proximal to both translocation breakpoints, which means that cEVI36 spans the t(1;17) breakpoint. Since probe BB2.1, a 2.1-kb ge- nomic BamHl fragment contained within cT315, maps to chromosome 17q and also is present in both translocation hybrids (Fig. 3e) , it is telomeric of both breakpoints. The contig, therefore, must span both NFl translocations and is oriented with cEVI36 closest to the centromere.
The t(1;17) breakpoint is localized within the contig by probe GG5.0, a 5kb BgZII fragment from cEVI36, which is adjacent to probe GE1.O and detects the same 11.5-kb genomic EcoRI fragment (Fig. 3~) . Unlike probe GE1.O, probe GG5.0 is present in hybrid DCRl, but on a 7.8-kb derivative EcuRI fragment that resulted from the translocation event, and absent from NF13.
The t( 17;22) breakpoint is localized by probe EE3.8, a 3.8-kb EcoRI fragment from cT311. In hybrid NF13, a 15-kb derivative fragment is present instead of the normal 3%kb EcoRI fragment (Fig. 3d ). An identical result was obtained when this experiment was repeated with the most distal 2.3-kb EcoRI fragment from cEVI20 (not shown), indicating that the position of the t(17;22) breakpoint lies within cEVI20. The two NFl translocation breakpoints thus define a candidate region for NFl of some 60 kb. The strong cross-hybridization of probe EE3.8 with a 3.35-kb murine genomic fragment suggests an evolutionary conservation of sequences in this region.
To investigate whether additional rearrangements of the translocation region take place in NFl, Southern transfers following PFGE of NruI, S&II, and Not1 digests of DNA from 38 independent NFl lymphoblastoid cell lines were examined with EVI2 sequences.
With the exception of the two translocations already mentioned, no qualitative changes (i.e., no new fragments) were observed. We would expect to have seen deletions as small as 40 kb had they been present.
To look for smaller deletions, we tested EcoRI and BamHI digests of DNA from 87 unrelated NFl patients for rearrangements or deletions with the pHU39.3 and E-9 probes, and BamHI digests with each of the four cosmids that define the EV12 contig encompassing the breakpoints.
We saw neither qualitative changes in the patterns seen (except for RFLPs with EcoRI and BamHI) nor quantitative reductions in signal intensities relative to control probes. Moreover, examination of the segregation of EcoRI, BamHI, and Tag1 RFLPs at the EVI2 locus in 51 NF1 families yielded no evidence for rearranged or deleted alleles at the EV12 locus.
DISCUSSION
Through a combination of genetic linkage analysis, somatic cell hybrid mapping, and PFGE analysis of large DNA fragments, a cloned segment of a specific human gene, EV12, has been found to lie between the breakpoints of two independent translocations in patients with NFl. This cloned human sequence is a bona fide homolog to the murine tumor-associated gene, as the DNA sequence, gene structure, and tissue specificity of its mRNA are closely related (Buchberg et al., submitted for publication; Cawthon et al., 1990) . PFGE analysis of DNA from the balanced t(17;22) LCL with the 17LlA, HU39.3, and E-9 probes failed to reveal derivative PFGE fragments in NotI, S&II, and BssHII digests. This initially suggested that the t(17;22) breakpoint might be located distally from the HTF "B" island. However, we now know that this is not the case, as these sites are not present in the two cosmids that span the t(17;22) breakpoint, cEVI20 or cT315. This HTF island must be more than 25 kb distal to the t(17;22) breakpoint, and a corresponding HTF island must be present on chromosome 22 near the translocation breakpoint. This may be by chance, but conceivably it could reflect a regional relationship of homology between these two chromosomes. Such a speculation is of particular interest because the chromosome 22 breakpoint region overlaps with the possible location of the bilateral acoustic neurofibromatosis (BANF or NF2) gene (Rouleau et al., 1990) .
The high incidence of new mutations leading to NFl (1 in 10,000 gametes per generation; Riccardi and Eichner, 1986) might suggest, by analogy with mutations leading to Duchenne muscular dystrophy , that frequent deletion or rearrangements may occur at the NFl locus. However, our failure to detect rearrangements or large deletions in the region of the two NFl translocation breakpoints suggests that this form of mutation-although it has occurred in the two cases that provided our translocation cell linesis not the predominant class of mutation at this part of the NFl locus.
Localization of E VI2 between two NFl translocation breakpoints is consistent with our a priori expectation for the mapping of the NFl gene. However, two additional transcripts apparently unrelated to EVI2 have been found between the two NFl translocation breakpoints, and a third transcript lies just telomeric to both NFl breakpoints (Cawthon et uZ., 1990) .
It seems likely that we are now either within or close to the NFl gene. This marks the completion of an important stage for NFl in the general paradigm for gene identification through mapping (Botstein et al., 1980; Monaco et uL., 1986; Friend et at., 1986; Royer-Pokora et al., 1986; Riordan et uZ., 1989) : an autosomal gene of unknown biochemistry has been precisely mapped through a combination of physical and genetic technologies, and components of expressed genes in the region have been identified (Cawthon et al., 1990) . It now remains to specify the NFl gene through identification of specific mutations in NFl patients.
